|
ZMYM4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.13370000007518E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.78709999999871E-05 |
| Normal-vs-Stage2 |
1.984090E-03 |
| Normal-vs-Stage3 |
2.4281999999598E-07 |
| Normal-vs-Stage4 |
1.12629999993175E-07 |
| Stage1-vs-Stage2 |
9.745400E-01 |
| Stage1-vs-Stage3 |
2.602400E-02 |
| Stage1-vs-Stage4 |
5.920600E-03 |
| Stage2-vs-Stage3 |
1.186440E-01 |
| Stage2-vs-Stage4 |
4.390400E-02 |
| Stage3-vs-Stage4 |
5.975400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.0931999999686E-06 |
| Normal-vs-AfricanAmerican |
1.345640E-02 |
| Normal-vs-Asian |
6.2388999999996E-05 |
| Caucasian-vs-AfricanAmerican |
6.225000E-01 |
| Caucasian-vs-Asian |
6.963000E-01 |
| AfricanAmerican-vs-Asian |
4.698600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.03310000000446E-05 |
| Normal-vs-Female |
3.46200000000962E-07 |
| Male-vs-Female |
5.741800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.96189999999952E-05 |
| Normal-vs-Age(41-60Yrs) |
3.56639999998798E-06 |
| Normal-vs-Age(61-80Yrs) |
3.50500000023679E-07 |
| Normal-vs-Age(81-100Yrs) |
2.011700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.945200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.097760E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.145000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.898800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.706400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.466400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.736200E-03 |
| Classical-VS-Follicular |
1.817440E-01 |
| Classical-VS-Other |
7.018800E-01 |
| Classical-VS-Normal |
5.50109999999382E-05 |
| Tall-VS-Follicular |
7.520000E-02 |
| Tall-VS-Other |
3.178800E-01 |
| Tall-VS-Normal |
3.10070000009155E-07 |
| Follicular-VS-Other |
9.519200E-01 |
| Follicular-VS-Normal |
4.24930000000323E-05 |
| Other-VS-Normal |
7.519800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.61135999999784E-05 |
| Normal-vs-N1 |
9.24620000009035E-07 |
| N0-vs-N1 |
1.864020E-01 |
|
|
